Healthcare - Biotechnology - NASDAQ - US
$ 4.0
-3.15 %
$ 239 M
Market Cap
8.89
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
22.38%
Net Income
Estimate
12.50%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Eledon Pharmaceuticals, Inc.
ELDN has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ELDN
EBIT FORECAST
EBIT Forecast Chart ELDN
NET INCOME FORECAST
Net Income Chart ELDN